Development of new glycosylation methodologies for the synthesis of Archaeal-Derived Glycolipid Adjuvants

  1. Get@NRC: Development of new glycosylation methodologies for the synthesis of Archaeal-Derived Glycolipid Adjuvants (Opens in a new window)
DOIResolve DOI:
AuthorSearch for: ; Search for: ; Search for: ; Search for:
Journal titleCarbohydrate Research
Pages214229; # of pages: 16
SubjectGlycosylation; Glycolipids; Adjuvants; MHC Type 1; CTL
AbstractTo commercialize the production of glycolipid adjuvants, their synthesis needs to be both robust and inexpensive. Herein we describe a semi-synthetic approach where the lipid acceptor is derived from the biomass of the archaeon Halobacterium salinarum, and the glycosyl donors are chemically synthesized. This work presents some preliminary results using the promoter system N-iodosuccinimide (NIS) and a stable 0.25 M solution of boron trifluoride-trifluoroethanol (BF₃·TFE₂) in dichloromethane. This promoter system allows for the use of peracetyl alkyl(aryl)thioglycosides that are available in high yield from inexpensive disaccharide starting materials by promoting clean glycosylation reactions from which pure product can be easily isolated. Conventional glycosylation using NIS-silver trifluoromethanesulfonate (AgOTf) leads to extensive acetyl transfer to the archaeol acceptor and numerous byproducts that make purification complicated. As part of preliminary structure-adjuvant activity studies, we describe the one-pot synthesis of a gentiobiose β-Glcp-(1→6)-Glcp-SEt donor with an O-2 benzoyl group, which can be used to prepare a disaccharide attached to archaeol in 85% overall yield, and the related glycolipid trisaccharide b-Glcp-(1→6)-β-Glcp-(1→6)-β-Glcp-(1→O)-archaeol. The synthesis of the isomeric β-Glcp-(1→6)-α-Glcp-(1→O)-archaeol featuring a >10:1 α/β α-selective glycosylation using the promoter system N-phenylselenylphthalimide-trifluoromethanesulfonic acid (TfOH) is also presented,along with the adjuvant properties of the corresponding archaeosomes (liposomes comprised entirely of combinations of isoprenoid archaeal-like lipids). These new vaccine formulations extend previous observations that glycolipids are integral to the activation of MHC type I pathways via CD8⁺ antigen-specific T-cells. The β-Glcp-(1→6)-β-Glcp-(1→6)-β-Glcp-(1→O)-archaeol trisaccharide is shown to be more active than the Glcp-(1→6)-β-Glcp-(1→O)-archaeol disaccharide.
Publication date
AffiliationNRC Institute for Biological Sciences; National Research Council Canada
Peer reviewedYes
NPARC number17435561
Export citationExport as RIS
Report a correctionReport a correction
Record identifiere5914dfb-f0c5-4a26-a1e8-dd0f0c590f03
Record created2011-03-30
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)